Patents-Review.com
ClassID:

97209 ⎘

C07K16/3076 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties

Sub-classes:
Recent Application in this class:
#1
20260116994
2026-04-30

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS

 #2
20260116950
2026-04-30

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS

 #3
20250312328
2025-10-09

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

 #4
20250297006
2025-09-25

Masked Multispecific Antigen-Binding Molecules with Cleavable Linkers

 #5
20250269027
2025-08-28

COMPOSITIONS AND METHODS FOR TREATING MESOTHELIN POSITIVE CANCERS

 #6
20250138018
2025-05-01

T CELL AND NK CELL ENGAGERS

 #7
20250092154
2025-03-20

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

 #8
20250084182
2025-03-13

ANTIBODY SPECIFIC FOR MUCIN-1 AND METHODS OF USE THEREOF

 #9
20250051857
2025-02-13

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

 #10
20250034276
2025-01-30

ANTI-GLYCAN ANTIBODIES AND USES THEREOF

 #11
20240409661
2024-12-12

Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof

 #12
20240376195
2024-11-14

ANTI-NKp30 ANTIBODIES AND METHODS OF USE

 #13
20240350474
2024-10-24

Antibody-drug conjugates and uses thereof

 #14
20240287186
2024-08-29

T CELL ACTIVATORS AND METHODS OF USE THEREOF

 #15
20240092935
2024-03-21

ANTI-TN ANTIBODIES AND USES THEREOF

 #16
20240084036
2024-03-14

MONOCLONAL ANTIBODIES AGAINST C-MET

 #17
20240059791
2024-02-22

TRIFUNCTIONAL FUSION PROTEIN CONTAINING TUMOR-ASSOCIATED ANTIGEN (TAA) ANTIBODY AND APPLICATION THEREOF

 #18
20240043561
2024-02-08

HUMANIZED ANTIBODIES AND FRAGMENTS THEREOF BINDING TO CARBOHYDRATE ANTIGENS AND USES THEREOF

 #19
20240000962
2024-01-04

Glycan-Interacting Compounds and Methods of Use

 #20
20230406927
2023-12-21

MASKED SINGLE-DOMAIN ANTIBODIES AND METHODS THEREOF

 #21
20230391885
2023-12-07

CLAUDIN 18.2 ANTIBODIES, METHODS OF MAKING THE SAME, AND USES THEREOF

 #22
20230365707
2023-11-16

NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A

 #23
20230357344
2023-11-09

Interleukin 15 Constructs and Methods of Use

 #24
20230331867
2023-10-19

NECTIN-4 ANTIBODIES AND USES THEREOF

 #25
20230227553
2023-07-20

ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF

 #26
20230226161
2023-07-20

CCR8 peptide and T cells for use in immunotherapeutic treatment of various cancers

 #27
20230212310
2023-07-06

ERIBULIN ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

 #28
20230212244
2023-07-06

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS

 #29
20230203190
2023-06-29

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS

 #30
20230203114
2023-06-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS

 #31
20230203113
2023-06-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS

 #32
20230181707
2023-06-15

Method for treating non-small lung cancer with a population of activated T cells

 #33
20230093265
2023-03-23

NEW METHOD AND COMPOUND FOR PROSTATE CANCER DIAGNOSIS

 #34
20230088845
2023-03-23

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS

 #35
20230086855
2023-03-23

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS

 #36
20230001007
2023-01-05

Glycan-Interacting Compounds and Methods of Use

 #37
20220387566
2022-12-08

Peptides and T cells for use in immunotherapeutic treatment of various cancers

 #38
20220356220
2022-11-10

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

 #39
20220340683
2022-10-27

ANTI-GLYCAN ANTIBODIES AND USES THEREOF

 #40
20220331413
2022-10-20

Peptides and T cells for use in immunotherapeutic treatment of various cancers

 #41
20220323560
2022-10-13

Peptides and T cells for use in immunotherapeutic treatment of various cancers

 #42
20220306765
2022-09-29

NOVEL ANTI-CLDN18.2 ANTIBODIES

 #43
20220288203
2022-09-15

Anti-podocalyxin antibodies and methods of using the same

 #44
20220267465
2022-08-25

BINDING MEMBERS

 #45
20220251215
2022-08-11

ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

 #46
20220249633
2022-08-11

Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma

 #47
20220249632
2022-08-11

Peptides and T cells for use in immunotherapeutic treatment of various cancers

 #48
20220249630
2022-08-11

GINS2 peptide and T cells for use in immunotherapeutic treatment of various cancers

 #49
20220233664
2022-07-28

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

 #50
20220233663
2022-07-28

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

 #51
20220227869
2022-07-21

ASSOCIATION OF POLYCLONAL ANTIBODIES AND ANTI-PD1 OR ANTI-PDL1 ANTIBODIES FOR TH TREATMENT OF CANCER

 #52
20220226452
2022-07-21

Method for treating non-small lung cancer with a population of activated cells

 #53
20220226451
2022-07-21

Peptides and T cells for use in immunotherapeutic treatment of various cancers

 #54
20220175898
2022-06-09

Peptides and T cells for use in immunotherapeutic treatment of various cancers

 #55
20220168345
2022-06-02

T CELL RECEPTORS AND METHODS OF USE THEREOF

 #56
20220160851
2022-05-26

Peptides and T cells for use in immunotherapeutic treatment of various cancers

 #57
20220135699
2022-05-05

CHIMERIC ANTIGEN RECEPTOR COMPRISING INTERLEUKIN-15 INTRACELLULAR DOMAIN AND USES THEREOF

 #58
20220057402
2022-02-24

Glycan-Interacting Compounds and Methods of Use

 #59
20220054648
2022-02-24

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

 #60
20220033514
2022-02-03

Antibody specific for Mucin-1 and methods of use thereof

 #61
20210346511
2021-11-11

IMMUNOCONJUGATES WITH AN INTRACELLULARLY-CLEAVABLE LINKAGE

 #62
20210317175
2021-10-14

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

 #63
20210292432
2021-09-23

Anti-glycan antibodies and uses thereof

 #64
20210269537
2021-09-02

Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof

 #65
20210246221
2021-08-12

CHIMERIC ANTIGEN RECEPTOR TARGETING SIALYL LEWIS A AND USES THEREOF

 #66
20210238304
2021-08-05

Eribulin antibody-drug conjugates and methods of use

 #67
20210145700
2021-05-20

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THEREOF

 #68
20210113711
2021-04-22

Conjugated biological molecules, pharmaceutical compositions and methods

 #69
20210079057
2021-03-18

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

 #70
20210069343
2021-03-11

Antibody-drug conjugates and uses thereof

 #71
20210033616
2021-02-04

L2A5 antibody or functional fragment thereof against tumour antigens

 #72
20210017290
2021-01-21

MONOCLONAL ANTIBODY SPECIFICALLY REACTING WITH NCC-ST-439 ANTIGEN AND METHOD FOR PRODUCING SAME

 #73
20210011021
2021-01-14

Glycan-Interacting Compounds and Methods of Use

 #74
20200397879
2020-12-24

Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers

 #75
20200385482
2020-12-10

HUMAN MONOCLONAL ANTI-PD-L1 ANTIBODIES AND METHODS OF USE

 #76
20200377612
2020-12-03

Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof

 #77
20200323968
2020-10-15

Method of treating with a peptide

 #78
20200299405
2020-09-24

Hydrogel composition for drug delivery and uses thereof

 #79
20200291129
2020-09-17

Methods and compositions for diagnosing and treating diseases

 #80
20200289631
2020-09-17

Method of treating with a peptide

 #81
20200276325
2020-09-03

Immunoconjugates with an intracellularly-cleavable linkage

 #82
20200262928
2020-08-20

Anti-MSLN antibody and pharmaceutical composition for cancer treatment comprising same

 #83
20200247900
2020-08-06

NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A

 #84
20200246481
2020-08-06

Antibody-drug conjugates and uses thereof

 #85
20200121805
2020-04-23

Immunoconjugates with an intracellularly-cleavable linkage

 #86
20200115465
2020-04-16

ANTIBODIES, BINDING FRAGMENTS, AND METHODS OF USE

 #87
20200085968
2020-03-19

Antibody-drug conjugates and uses thereof

 #88
20200079872
2020-03-12

Monoclonal antibodies against c-Met

 #89
20200078452
2020-03-12

NOVEL GLYCAN CONJUGATES AND METHODS OF USE THEREOF

 #90
20200061170
2020-02-27

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

 #91
20200054729
2020-02-20

Method of treating with a peptide

 #92
20200024317
2020-01-23

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS

 #93
20200002395
2020-01-02

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

 #94
20200000932
2020-01-02

Glycan-interacting compounds and methods of use

 #95
20190322759
2019-10-24

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

 #96
20190284297
2019-09-19

Anti-CD3 epsilon antibodies and methods of use thereof

 #97
20190167805
2019-06-06

Immunoconjugates with an intracellularly-cleavable linkage

 #98
20190105405
2019-04-11

Anti-metalloprotease antibody for diagnosis and treatment of cancers

 #99
20190085093
2019-03-21

Composition for regulating cell division comprising FCHO1 modulator, and method for regulating cell division using same

 #100
20190085092
2019-03-21

Anti-Sialyl Tn chimeric antigen receptors

 #101
20190070308
2019-03-07

Antibody-drug conjugates and uses thereof

 #102
20190040155
2019-02-07

Multivalent FV antibodies

 #103
20190002559
2019-01-03

Antibodies specific for Trop-2 and their uses

 #104
20180371103
2018-12-27

ANTIBODIES AGAINST IMMUNOGENIC GLYCOPEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USE THEREOF

 #105
20180371088
2018-12-27

TARGET CELL-DEPENDENT T CELL ENGAGING AND ACTIVATION ASYMMETRIC HETERODIMERIC Fc-ScFv FUSION ANTIBODY FORMAT AND USES THEREOF IN CANCER THERAPY

 #106
20180346587
2018-12-06

Human monoclonal anti-PD-L1 antibodies and methods of use

 #107
20180318439
2018-11-08

Immunoconjugates with an intracellularly-cleavable linkage

 #108
20180296673
2018-10-18

Anti-podocalyxin antibodies and methods of using the same

 #109
20180291109
2018-10-11

Antibodies, binding fragments, and methods of use

 #110
20180265591
2018-09-20

METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES

 #111
20180258182
2018-09-13

Humanized anti-TF-antigen antibodies

 #112
20180258150
2018-09-13

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

 #113
20180251568
2018-09-06

CSGP4—specific chimeric antigen receptor for cancer

 #114
20180251507
2018-09-06

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

 #115
20180244741
2018-08-30

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

 #116
20180193481
2018-07-12

Conjugated biological molecules, pharmaceutical compositions and methods

 #117
20180154016
2018-06-07

DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #118
20180142034
2018-05-24

Chimeric antigen receptors and uses thereof

 #119
20180134800
2018-05-17

Human monoclonal antibodies specific for glypican-3 and use thereof

 #120
20180100022
2018-04-12

HER1 ANTIGEN BINDING PROTEINS BINDING TO THE BETA-HAIRPIN OF HER1

 #121
20180057603
2018-03-01

Combination of IFN-gamma with Anti-ERBB Antibody for the Treatment of Cancers

 #122
20180037663
2018-02-08

Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)

 #123
20180028634
2018-02-01

METHOD FOR PROLONGING AND ENHANCING ANTI-TUMOR VACCINE RESPONSE

 #124
20170362337
2017-12-21

Antibodies against immunogenic glycopeptides, compositions comprising the same and use thereof

 #125
20170362333
2017-12-21

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

 #126
20170342140
2017-11-30

Monoclonal antibody reacting with glycopeptide, and use thereof

 #127
20170320963
2017-11-09

Genetic products differentially expressed in tumors and the use thereof

 #128
20170320962
2017-11-09

MONOCLONAL ANTIBODIES AGAINST C-MET

 #129
20170313782
2017-11-02

MONOCLONAL ANTIBODIES AGAINST C-MET

 #130
20170306046
2017-10-26

GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

 #131
20170266316
2017-09-21

Immunoconjugates with an intracellularly-cleavable linkage

 #132
20170247417
2017-08-31

T-cell redirecting bispecific antibodies for treatment of disease

 #133
20170240646
2017-08-24

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THEREOF

 #134
20170239368
2017-08-24

Immunoconjugates with an intracellularly-cleavable linkage

 #135
20170218080
2017-08-03

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

 #136
20170210825
2017-07-27

MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE

 #137
20170136108
2017-05-18

NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

 #138
20170107297
2017-04-20

Antibodies against immunogenic glycopeptides, compositions comprising the same and use thereof

 #139
20170100491
2017-04-13

AURISTATIN TYRAMINE PHOSPHATE SALTS AND AURISTATIN AMINOQUINOLINE DERIVATIVES AND PRODRUGS THEREOF

 #140
20170058051
2017-03-02

Covalently linked polypeptide toxin-antibody conjugates

 #141
20170056488
2017-03-02

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

 #142
20170056486
2017-03-02

Method for treating cancer with activated T cells

 #143
20170043033
2017-02-16

Antibody-drug conjugates with high drug loading

 #144
20170029528
2017-02-02

Humanized anti-TF-antigen antibodies

 #145
20170028081
2017-02-02

Immunoconjugates with an intracellularly-cleavable linkage

 #146
20170022274
2017-01-26

T-cell redirecting bispecific antibodies for treatment of disease

 #147
20170014527
2017-01-19

Antibody-drug conjugates and uses thereof

 #148
20160376375
2016-12-29

CSGP4 - Specific Chimeric Antigen Receptor for Cancer

 #149
20160347808
2016-12-01

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

 #150
20160346371
2016-12-01

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

 #151
20160339092
2016-11-24

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

 #152
20160333110
2016-11-17

Anti-human TROP-2 antibody having an antitumor activity in vivo

 #153
20160326235
2016-11-10

Antibody possessing an affinity for epithelial secretory and nervous tissue, as well as tumour tissue derived from these tissues as well as the use thereof

 #154
20160257746
2016-09-08

Antibodies specific for TROP-2 and their uses

 #155
20160250350
2016-09-01

DELIVERY SYSTEM FOR CYTOTOXIC DRUGS BY BISPECIFIC ANTIBODY PRETARGETING

 #156
20160220695
2016-08-04

Immunoconjugates with an intracellularly-cleavable linkage

 #157
20160213763
2016-07-28

Glycan conjugates and methods of use thereof

 #158
20160208015
2016-07-21

Human monoclonal antibodies specific for glypican-3 and use thereof

 #159
20160184450
2016-06-30

DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #160
20160176980
2016-06-23

T-cell redirecting bispecific antibodies for treatment of disease

 #161
20160176979
2016-06-23

Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)

 #162
20160137743
2016-05-19

Glycan-interacting compounds

 #163
20160082003
2016-03-24

Immunoconjugates with an intracellularly-cleavable linkage

 #164
20160002346
2016-01-07

HER1 antigen binding proteins binding to the beta-hairpin of HER1

 #165
20150361181
2015-12-17

METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES

 #166
20150353644
2015-12-10

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

 #167
20150343087
2015-12-03

Class I anti-CEA antibodies and uses thereof

 #168
20150337052
2015-11-26

Genetic Products Differentially Expressed In Tumors And The Use Thereof

 #169
20150329642
2015-11-19

Monoclonal antibodies against c-Met

 #170
20150274838
2015-10-01

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

 #171
20150274835
2015-10-01

Human monoclonal anti-PD-L1 antibodies and methods of use

 #172
20150259434
2015-09-17

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

 #173
20150258194
2015-09-17

MODULATING TRANSENDOTHELIAL MIGRATION AND RECRUITMENT OF GRANULOCYTES BY MODULATING C-MET PATHWAY

 #174
20150166679
2015-06-18

Secretory immunoglobulin complex

 #175
20150152187
2015-06-04

Anti-PSMA Antibodies Conjugated to Nuclear Receptor Ligand Polypeptides

 #176
20150111279
2015-04-23

Class I anti-CEA antibodies and uses thereof

 #177
20150087806
2015-03-26

Glycopeptide and uses thereof

 #178
20150056134
2015-02-26

Nucleic acids encoding human antibodies to sialyl-lewis

 #179
20140357844
2014-12-04

Antibodies specific for trop-2 and their uses

 #180
20140286973
2014-09-25

Chimeric antigen receptor specific for folate receptor β

 #181
20140212473
2014-07-31

Glycopeptide and uses thereof

 #182
20140178365
2014-06-26

Glycan-interacting compounds

 #183
20140113979
2014-04-24

Compositions and methods for detecting cancer

 #184
20140105899
2014-04-17

Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same

 #185
20140099259
2014-04-10

Tumor-specific recognition molecules

 #186
20130344509
2013-12-26

Anti-human TROP-2 antibody having an antitumor activity in vivo

 #187
20130336894
2013-12-19

Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications

 #188
20130280246
2013-10-24

Humanized antibodies with anti-tumor activity

 #189
20130158236
2013-06-20

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

 #190
20130122020
2013-05-16

Antibodies specific for Trop-2 and their uses

 #191
20130039849
2013-02-14

Adenocarcinoma specific antibody SAM-6, and uses thereof

 #192
20130034492
2013-02-07

Class I anti-CEA antibodies and uses thereof

 #193
20120321614
2012-12-20

Antibodies to c-Met

 #194
20120270802
2012-10-25

Binding molecules for the treatment of myeloid cell malignancies

 #195
20120258091
2012-10-11

Genetic products differentially expressed in tumors and the use thereof

 #196
20120219560
2012-08-30

De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #197
20120195901
2012-08-02

Compositions and Methods for Binding Lysophosphatidic Acid

 #198
20120183545
2012-07-19

CD20-binding polypeptide compositions for treating autoimmune disease

 #199
20120149877
2012-06-14

Tumor-specific recognition molecules

 #200
20120107235
2012-05-03

Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof

 #201
20120082618
2012-04-05

Prostate cancer diagnosis and treatment

 #202
20120082617
2012-04-05

Immunoconjugates with an intracellularly-cleavable linkage

 #203
20120039984
2012-02-16

GLYCOPEPTIDE AND USES THEREOF

 #204
20110293513
2011-12-01

Immunoconjugates with an intracellularly-cleavable linkage

 #205
20110280888
2011-11-17

Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same

 #206
20110256137
2011-10-20

Pharmaceutical composition comprising a bispecific antibody for EpCAM

 #207
20110250204
2011-10-13

Methods and compositions for diagnosing and treating diseases

 #208
20110229476
2011-09-22

Monospecific and multispecific antibodies and method of use

 #209
20110229407
2011-09-22

Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof

 #210
20110177614
2011-07-21

COMPOSITIONS AND METHODS FOR DETECTING CANCER

 #211
20110158902
2011-06-30

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

 #212
20110135633
2011-06-09

Methods for treating chronic lymphocytic leukemia

 #213
20110129471
2011-06-02

Chronic lymphocytic leukemia cell line

 #214
20110064744
2011-03-17

PREVENTION AND TREATMENT OF PAIN USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID

 #215
20110064654
2011-03-17

Prostate cancer diagnosis and treatment

 #216
20110064653
2011-03-17

Class I anti-CEA antibodies and uses thereof

 #217
20110002922
2011-01-06

Cell growth inhibitors containing anti-glypican 3 antibody

 #218
20100310559
2010-12-09

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

 #219
20100303715
2010-12-02

Prostate-specific membrane antigen and uses thereof

 #220
20100298545
2010-11-25

EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

 #221
20100297134
2010-11-25

Humanised antibodies with anti-tumour activity

 #222
20100297008
2010-11-25

Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors

 #223
20100292095
2010-11-18

HUMAN MONOCLONAL ANTIBODIES DIRECTED TO SIALYL LEWIS C, SIALYL TN AND N GLYCOLYLNEURAMINIC ACID EPITOPES AND A METHOD OF ANALYSIS OF STEM CELLS COMPRISING SAID EPITOPES

 #224
20100278818
2010-11-04

Antibody specific for the Tn antigen for the treatment of cancer

 #225
20100260762
2010-10-14

De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #226
20100247536
2010-09-30

Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications

 #227
20100239598
2010-09-23

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

 #228
20100218267
2010-08-26

Methods for producing antibodies

 #229
20100196989
2010-08-05

Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof

 #230
20100184671
2010-07-22

Binding molecules for the treatment of myeloid cell malignancies

 #231
20100158802
2010-06-24

Chimeric, human and humanized anti-CSAP monoclonal antibodies

 #232
20100143345
2010-06-10

EPHA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

 #233
20100104589
2010-04-29

Immunoconjugates with an intracellularly-cleavable linkage

 #234
20100099148
2010-04-22

Vectors for production of antibodies

 #235
20100081795
2010-04-01

RG1 ANTIBODIES AND USES THEREOF

 #236
20100040629
2010-02-18

Antibodies to c-Met

 #237
20100034814
2010-02-11

Compositions and methods for binding lysophosphatidic acid

 #238
20090324619
2009-12-31

Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain

 #239
20090324617
2009-12-31

Cancer specific glycans and use thereof

 #240
20090220523
2009-09-03

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY AND NEOVASCULARIZATION CONDITIONS

 #241
20090208498
2009-08-20

Genetic products differentially expressed in tumors and the use thereof

 #242
20090202580
2009-08-13

Method for the preparation of specific antibodies against saccharidic antigens

 #243
20090196916
2009-08-06

Liposome-mediated ligation

 #244
20090191221
2009-07-30

Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same

 #245
20090155817
2009-06-18

Genetic products differentially expressed in tumors and the use of thereof

 #246
20090136483
2009-05-28

Compositions and methods for binding lysophosphatidic acid

 #247
20090041836
2009-02-12

Glycolipopeptide antibodies

 #248
20090022745
2009-01-22

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

 #249
20090017046
2009-01-15

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

 #250
20080227965
2008-09-18

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

 #251
20080226656
2008-09-18

RG1 antibodies and uses thereof

 #252
20080219920
2008-09-11

Chimeric, human and humanized anti-CSAp monoclonal antibodies

 #253
20080193460
2008-08-14

Chimeric, human and humanized anti-CSAP monoclonal antibodies

 #254
20080193451
2008-08-14

Chimeric, human and humanized anti-CSAp monoclonal antibodies

 #255
20080166350
2008-07-10

Genetic products differentially expressed in tumors and the use thereof

 #256
20080146784
2008-06-19

Alpha-fetoprotein Immu31 antibodies and fusion proteins

 #257
20080138899
2008-06-12

RG1 antibodies and uses thereof

 #258
20080118936
2008-05-22

POLYCLONAL ANTIBODIES AGAINST FIBRINOGEN DEGRADATION PRODUCTS AND ASSOCIATED METHODS OF PRODUCTION AND USE

 #259
20080108133
2008-05-08

Adenocarcinoma specific antibody SAM-6, and uses thereof

 #260
20080096234
2008-04-24

Method for examining carcinoma and adenoma

 #261
20080089838
2008-04-17

Chimeric, human and humanized anti-CSAP monoclonal antibodies

 #262
20070281320
2007-12-06

Bioactive lipid derivatives, and methods of making and using same

 #263
20070280933
2007-12-06

Methods for decreasing immune response and treating immune conditions

 #264
20070243201
2007-10-18

Method for Selecting Epitopes for Immunotherapy

 #265
20070196346
2007-08-23

Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer

 #266
20070172488
2007-07-26

Cell growth inhibitors containing anti-glypican 3 antibody

 #267
20070148168
2007-06-28

Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions

 #268
20070141068
2007-06-21

METHODS FOR THE TREATMENT OF CARCINOMA

 #269
20070134254
2007-06-14

EphA2 agonistic monoclonal antibodies and methods of use thereof

 #270
20070098724
2007-05-03

Methods of treatment using vascular occlusion in combination therapies

 #271
20070086943
2007-04-19

EphA2 agonistic monoclonal antibodies and methods of use thereof

 #272
20070081993
2007-04-12

Pharmaceutical composition comprising a bispecific antibody for EpCAM

 #273
20070036719
2007-02-15

Prostate cancer diagnosis and treatment

 #274
20070020276
2007-01-25

METHODS FOR THE TREATMENT OF CARCINOMA

 #275
20070020273
2007-01-25

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

 #276
20060251668
2006-11-09

Tumor-specific recognition molecules

 #277
20060228299
2006-10-12

Constructs binding to phosphatidylserine and their use in disease treatment

 #278
20060177451
2006-08-10

Binding molecules for the treatment of myeloid cell malignancies

 #279
20060171946
2006-08-03

Compositions and methods for the treatment and prevention of hyperproliferative diseases

 #280
20060148013
2006-07-06

Tumor marker and its use

 #281
20060035852
2006-02-16

Genetic products differentially expressed in tumors and the use thereof

 #282
20050287145
2005-12-29

Compositions and methods for producing vascular occlusion

 #283
20050281825
2005-12-22

Cell growth inhibitor containing anti-PepT antibody

 #284
20050222391
2005-10-06

Methods for producing antibody

 #285
20050169926
2005-08-04

Chimeric, human and humanized anti-CSAp monoclonal antibodies

 #286
20050152899
2005-07-14

EphA2 agonistic monoclonal antibodies and methods of use thereof

 #287
20050129690
2005-06-16

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

 #288
20050118185
2005-06-02

Recombinant immunoreceptors

 #289
20050100957
2005-05-12

Chronic lymphocytic leukemia cell line

 #290
20050074452
2005-04-07

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

 #291
20050069545
2005-03-31

CD20-binding polypeptide compositions and methods

 #292
20050069535
2005-03-31

Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides

 #293
20050054019
2005-03-10

Antibodies to c-Met

 #294
20050042636
2005-02-24

Compositions and methods for detecting abnormal cell proliferation

 #295
20050032101
2005-02-10

Methods for diagnosis and therapy of cancer and composition useful therein

 #296
20050019845
2005-01-27

RG1 antibodies and uses thereof